default author photo

Yun Peng

Xiamen University

SCHOLARLY PAPERS

1

DOWNLOADS

85

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Mufemilast in Patients with Behcet's Syndrome: A Phase 2, Double-Blind, Placebo-Controlled Trial

Number of pages: 28 Posted: 08 Sep 2025
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Tongji University - Shanghai Tongji Hospital, Wenzhou Medical University, Xiamen University, Xuzhou Medical University, Xuzhou Medical University, Peking University - Department of Rheumatology and Clinical Immunology, Government of the People's Republic of China - Beijing Hospital, Sun Yat-sen University (SYSU) - Department of Rheumatology, Sun Yat-sen University (SYSU) - Sun Yat-sen Memorial Hospital, Zhejiang University, Zhejiang University, The People’s Hospital of Xin Jiang Uygur Autonomous Region - Department of Rheumatology and Immunology, Linyi People's Hospital, Zhengzhou University - Department of Rheumatology, University of Science and Technology of China (USTC), Fudan University, Soochow University, Capital Medical University, Jilin Province People’s Hospital, Jilin Province People’s Hospital, The University of Hong Kong, Baotou Medical College, Fudan University, Fudan University, Nanjing Medical University - Jiangsu Province Hospital, Jilin University (JLU), Hangzhou Medical College - Zhejiang Provincial People’s Hospital, Chengdu Medical College, Ganzhou Hemay Pharmaceutical Co., Ltd, Ganzhou Hemay Pharmaceutical Co., Ltd and Peking University - Department of Rheumatology and Immunology
Downloads 85 (771,553)

Abstract:

Loading...

Behcet desease, phosphodiesterase inhibitor, PDE inhibitor, oral ulcer